Analysis of long-term outcomes of 3200 liver transplantations over two decades - A single-center experience

被引:316
作者
Busuttil, RW
Farmer, DG
Yersiz, H
Hiatt, JR
McDiarmid, SV
Goldstein, LI
Saab, S
Han, S
Durazo, F
Weaver, M
Cao, C
Chen, T
Lipshutz, GS
Holt, C
Gordon, S
Gornbein, J
Amersi, F
Ghobrial, RM
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Liver Transplant Ctr, Dept Surg, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Dumont UCLA, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Dumont UCLA, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Dumont UCLA, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Dumont UCLA, Los Angeles, CA 90095 USA
关键词
D O I
10.1097/01.sla.0000164077.77912.98
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Few studies have evaluated long-term outcomes after orthotopic liver transplantation (OLT). This work analyzes the experience of nearly 2 decades by the same team in a single center. Outcomes of OLT and factors affecting survival were analyzed. Methods: Retrospective analysis of 3200 consecutive OLTs that were performed at our institution, between February 1984 and December 31, 2001. Results: Of 2662 recipients, 578 (21.7%) and 659 (24.7%) were pediatric and urgent patients, respectively. Overall 1-, 5-, 10-, and 15-year patient and graft survival estimates were 81%, 72%, 68%, 64% and 73%, 64%, 59%, 55%, respectively. Patient survival significantly improved in the second (1992-2001) versus the era 1 (1984-1991) of transplantation (P < 0.001). Similarly, graft survival was better in the era II of transplantation (P < 0.02). However, biliary and infectious complications increased in era II. When OLT indications were considered, best recipient survival was obtained in children with biliary atresia (82%, 79%, and 78% at 1, 5, and 10 years, respectively), while malignant disease in adult patients resulted in the worst outcomes of 68% and 43% at 1 and 5 years, post-OLT. Further, patients < 18 years and nonurgent recipients exhibited superior survival when compared with recipients > 18 years (P < 0.001) or urgent patients (P < 0.001). Of 13 donor and recipient variables, era of OLT, recipient age, urgent status, donor age, donor length of hospital stay, etiology of liver disease, retrans- plantation, warm and cold ischemia, but not graft type (whole, split, living-donor), significantly impacted patient survival. Conclusions: Long-term benefits of OLT are greatest in pediatric and nonurgent patients. Multiple factors involving the recipient, etiology of liver disease, donor characteristics, operative variables, and surgical experience influence long-term survival outcomes. By balancing and matching these factors with a given recipient, optimum results can be achieved.
引用
收藏
页码:905 / 916
页数:12
相关论文
共 50 条
[11]  
COOPER JD, 1987, J THORAC CARDIOV SUR, V93, P173
[12]   EARLY DEATH OR RETRANSPLANTATION IN ADULTS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - CAN OUTCOME BE PREDICTED [J].
DOYLE, HR ;
MARINO, IR ;
JABBOUR, N ;
ZETTI, G ;
MCMICHAEL, J ;
MITCHELL, S ;
FUNG, J ;
STARZL, TE .
TRANSPLANTATION, 1994, 57 (07) :1028-1036
[13]   Hepatic retransplantation - An analysis of risk factors associated with outcome [J].
Doyle, HR ;
Morelli, F ;
McMichael, J ;
Doria, C ;
Aldrighetti, L ;
Starzl, TE ;
Marino, IR .
TRANSPLANTATION, 1996, 61 (10) :1499-1505
[14]   Early graft function after pediatric liver transplantation - Comparison between in situ split liver grafts and living-related liver grafts [J].
Farmer, DG ;
Yersiz, H ;
Ghobrial, RM ;
McDiarmid, SV ;
Gornbein, J ;
Le, H ;
Schlifke, A ;
Amersi, F ;
Maxfield, A ;
Amos, N ;
Restrepo, GC ;
Chen, P ;
Dawson, S ;
Busuttil, RW .
TRANSPLANTATION, 2001, 72 (11) :1795-1802
[15]  
FONKALSRUD EW, 1968, SURG GYNECOL OBSTETR, V127, P1051
[16]   Retransplantation for recurrent hepatitis C in the model for end-stage liver disease era: How should we or shouldn't we? [J].
Ghobrial, RM .
LIVER TRANSPLANTATION, 2003, 9 (10) :1025-1027
[17]   Pretransplant model to predict posttransplant survival in liver transplant patients [J].
Ghobrial, RM ;
Gornbein, J ;
Steadman, R ;
Danino, N ;
Markmann, JF ;
Holt, C ;
Anselmo, D ;
Amersi, F ;
Chen, P ;
Farmer, DG ;
Han, S ;
Derazo, F ;
Saab, S ;
Goldstein, LI ;
McDiarmid, SV ;
Busuttil, RW .
ANNALS OF SURGERY, 2002, 236 (03) :315-323
[18]   Retransplantation for recurrent hepatitis C [J].
Ghobrial, RM .
LIVER TRANSPLANTATION, 2002, 8 (10) :S38-S43
[19]   Donor and recipient outcomes in right lobe adult living donor liver transplantation [J].
Ghobrial, RM ;
Saab, S ;
Lassman, C ;
Lu, DSK ;
Raman, S ;
Limanond, P ;
Kunder, G ;
Marks, K ;
Amersi, T ;
Anselmo, D ;
Chen, P ;
Farmer, D ;
Han, S ;
Durazo, F ;
Goldstein, LI ;
Busuttil, RW .
LIVER TRANSPLANTATION, 2002, 8 (10) :901-909
[20]   A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients [J].
Ghobrial, RM ;
Steadman, R ;
Gornbein, J ;
Lassman, C ;
Holt, CD ;
Chen, P ;
Farmer, DG ;
Yersiz, H ;
Danino, N ;
Collisson, E ;
Baquarizo, A ;
Han, SS ;
Saab, S ;
Goldstein, LI ;
Donovan, JA ;
Esrason, K ;
Busuttil, RW .
ANNALS OF SURGERY, 2001, 234 (03) :384-393